CTC
REGN icon

Cetera Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Cetera Trust Company’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$5.7K – 389
2024
Q4 		$5.7K Hold
8
– – ﹤0.01% 344
2024
Q3 		$8.41K Hold
8
– – 0.01% 321
2024
Q2 		$8.41K Hold
8
– – 0.01% 310
2024
Q1 		$7.7K Hold
8
– – ﹤0.01% 331
2023
Q4 		$7.03K Buy
+8
New +$6.59K ﹤0.01% 330

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cetera Trust Company's REGN Position: Q1 2025 in Review

Cetera Trust Company sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 8 shares — an estimated $5.7K sold.

Cetera Trust Company first reported a position in REGN in Q4 2023 and held it in 5 quarters. The position peaked at $8.41K in Q3 2024. 1,290 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Cetera Trust Company reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Cetera Trust Company sold 8 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $5.7K.
  • Cetera Trust Company first reported a position in Regeneron Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Cetera Trust Company's Regeneron Pharmaceuticals position peaked at $8.41K in Q3 2024.
  • 1,290 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Cetera Trust Company's 13F filing for Q1 2025, filed 14 Apr 2025.